1 Cardiovascular Center, Azienda Sanitaria-Universitaria Integrata of Trieste, Trieste, Italy.
2 Department of Cardiology, Villa Bianca Hospital, Trento, Italy.
Eur J Prev Cardiol. 2017 Oct;24(15):1584-1593. doi: 10.1177/2047487317726068. Epub 2017 Aug 16.
Background The CHADS-VASc score well stratifies the risk for thromboembolic events in non-valvular atrial fibrillation (NVAF) patients. This score may also predict thromboembolic events in sinus rhythm populations. Purpose The purpose of this study was to assess the prognostic role of CHADS-VASc in a Caucasian community population of patients with arterial hypertension and sinus rhythm. Methods A total of 12,599 arterial hypertension residents not receiving anticoagulation were selected from a community population in Trieste between November 2009 and October 2014: 11,159 sinus rhythm and 1440 NVAF patients. We considered thromboembolic events, cardiovascular hospitalisation and all-cause death in all patients divided according to CHADS-VASc. Results Sinus rhythm patients were 74 (interquartile range 65-81) years old, 50% were women, 32% with CAD, mean CHADS-VASc 3.68 ± 1.47 points, significantly lower than NVAF patients (4.26 ± 1.50, P < 0.001). After 37 months follow-up, an increasing CHADS-VASc corresponded to a higher rate of thromboembolic events in sinus rhythm patients, ranging from 0% in patients with a score of 1 or 2 to 2.6% in those with a score of 6 or greater ( P < 0.0001). A similar trend was found in the reference NVAF group. At Cox multivariable analysis, CHADS-VASc predicted thromboembolic events (hazard ratio (HR) 2.12), cardiovascular hospitalisation (HR 1.55) and all-cause death (HR 1.57). The predictive accuracy of CHADS-VASc was similar in sinus rhythm and NVAF patients for thromboembolic events, cardiovascular hospitalisation and all-cause death (area under the curve statistic 0.76 vs. 0.76, 0.68 vs. 0.66, 0.64 vs. 0.64, respectively). Conclusions In a community population of Caucasian arterial hypertension patients in sinus rhythm, CHADS-VASc rather well stratifies for adverse clinical events at mid-term follow-up with a similar accuracy to NVAF patients. These results might be clinically relevant in this setting of sinus rhythm patients.
CHADS-VASc 评分可很好地分层非瓣膜性心房颤动(NVAF)患者的血栓栓塞事件风险。该评分也可能预测窦性心律人群中的血栓栓塞事件。
本研究旨在评估 CHADS-VASc 在一个白种人社区人群中患有动脉高血压和窦性心律的患者中的预后作用。
2009 年 11 月至 2014 年 10 月,从的里雅斯特的一个社区人群中选择了 12599 名未接受抗凝治疗的动脉高血压居民:11159 名窦性心律和 1440 名 NVAF 患者。我们根据 CHADS-VASc 将所有患者分为血栓栓塞事件、心血管住院和全因死亡。
窦性心律患者年龄为 74 岁(四分位距 65-81 岁),50%为女性,32%患有 CAD,平均 CHADS-VASc 为 3.68±1.47 分,明显低于 NVAF 患者(4.26±1.50,P<0.001)。在 37 个月的随访后,CHADS-VASc 评分的增加与窦性心律患者的血栓栓塞事件发生率的增加相关,从评分 1 或 2 的患者的 0%到评分 6 或更高的患者的 2.6%(P<0.0001)。在参考 NVAF 组中也发现了类似的趋势。在 Cox 多变量分析中,CHADS-VASc 预测了血栓栓塞事件(危险比(HR)2.12)、心血管住院(HR 1.55)和全因死亡(HR 1.57)。CHADS-VASc 对窦性心律和 NVAF 患者的血栓栓塞事件、心血管住院和全因死亡的预测准确性相似(曲线下面积统计值分别为 0.76 对 0.76、0.68 对 0.66、0.64 对 0.64)。
在窦性心律的白种人社区人群中,CHADS-VASc 可很好地分层中期随访时的不良临床事件,其准确性与 NVAF 患者相似。这些结果在窦性心律患者的这种情况下可能具有临床意义。